Oncotarget (2016) 7:17393409
31 (Supplement), 155161
Chalasani 1 , Shusuke Toden 2 , Rhys De Sota 2 and John J Sninsky 2 , (1)Indiana University School of Medicine, (2)Molecular Stethoscope Background: Emerging evidence indicates that non-alcoholic fatty liver disease (NAFLD) is associated with increased rates of dementia and poor cognitive performance
The long, high-cost, and resource-heavy process of developing AD medications, coupled with their high rate of failure, has led to growing interest in repurposing medications originally designed for other conditions, including cancer, cardiovascular diseases, psychiatric disorders, diabetes, and other neurological diseases
doi: 10.21037/tp.2019.09.09
And Ive seen too many people waste money on supplements that never had a chance